Key Points
Torrent Pharma has joined the race to buy out the Hamied family's stake in Cipla, said people aware of the matter, in what could be the biggest pharma deal since 2014..
Sixth-ranked Torrent is aiming to take control of the fourth-ranked Indian drugmaker that's more than double (2.3x) its FY23 consolidated revenue, 2.3 times its profit and 1.46 times its present market value..
A transaction could eventually lead to the creation of India's second-biggest drugmaker after Sun Pharma by revenue...
Torrent, advised by JP Morgan, is looking to form a consortium with private equity funds and has had preliminary discussions with a few.. . Lenders tapped..
The Sudhir and Samir Mehta family own 71.25% of Torrent, among the highest promoter ownership in Indian pharma, and have the headroom to dilute equity to raise leverage, according to a person with knowledge of the matter...
You might be interested in
Torrent in top gear to close out Cipla buyout, in talks with PEs, banks for funds
01, Sep, 23Rival contenders Blackstone, Baring Asia hit pause mode as Cipla valuations soar. Torrent taps PE funds like Warburg Pincus, CVC among others to raise around $1 bn before submitting binding offer by early October.
Cipla in advanced talks with 2 groups
27, Sep, 23Promoters in talks with consortiums led by Torrent and Baring
Family office of Gland Pharma's former promoter acquires GBJ Hotels
21, Oct, 23KP Advisory Services, the family office of the promoter Ravi Penmetsa, acquired the five-star property last week in Coimbatore under the corporate insolvency process, the people cited above said. Lenders unanimously voted for KP Advisory Services' Rs 185-crore plan. The resolution professional (RP) had admitted Rs 196 crore in claims, including trade creditors and banks. The offer from the family office of Gland Pharmas ex-promoters equates to a recovery of 94% for creditors.